Pediatric allergic rhinitis: current and future state of the art.
Allergic rhinitis (AR) is the most common cause of allergic disease in the pediatric population. This chronic condition impacts quality of life, exacerbates comorbid conditions, and results in a significant economic burden. With an accurate diagnosis, there are many available therapies to reduce the burden of AR. Options include allergen avoidance, pharmacotherapy, and immune modulation. This review provides a comprehensive discussion of the current and future state of the art in the treatment of pediatric AR.
Carr
Warner W
WW
Allergy and Asthma Associates of Southern California, Viejo, California 92691, USA. warnercarr@hotmail.com
D018926:Anti-Allergic Agents / Q000627:therapeutic use; D002648:Child; D003888:Desensitization, Immunologic; D006801:Humans; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy / Q000628:therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy / Q000628:therapy*
D018926:Anti-Allergic Agents